| Active Market | Forge Price1 | Last Funding Round | Trade Eligibility | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Sector & Subsector | Market Activity4   |
Highest Bid | Lowest Ask | Last Matched | +/- to LFR | $ Total Bids | $ Total Asks | # Bids | # Asks | Current Price |
6-month |
1-year |
Total Funding |
Round | Date | Amount Raised |
Post-Money Valuation3 |
Price |
Key Investors | Common | Preferred | Fund | ||
 | MycoWorks | Industrial Materials | Low | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $386.69MM | Series D-1 | 8/9/2024 | $190.13MM | $436.23MM | $2.03 | SOSV, IndieBio | ||||
 | Aiolos Bio | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $247.55MM | Series A | 10/24/2023 | $180MM | $436.12MM | $1.19 | Atlas Venture, Bain Capital Life Sciences, Forbion, Sofinnova Investments, RA Capital Management | ||||
 | RainFocus | Consumer & Lifestyle Consumer & Lifestyle Enterprise Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $93.41MM | Series C-1 | 9/9/2021 | $45MM | $435.81MM | $29.21 | KKR, JMI Equity | ||||
 | Haus | Technology Hardware Other Technology Hardware | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $61.65MM | Series A-3 | 4/18/2025 | $18.3MM | $435.72MM | $8.28 | Undisclosed Investors | ||||
 | Tome Biosciences | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $245.57MM | Series B | 12/12/2023 | $150MM | $435.54MM | $3.03 | Andreessen Horowitz, ARCH Venture Partners, GV, Longwood Fund, Polaris Partners, Bruker Corporation, FUJIFILM Corporation, Alexandria Venture Investments | ||||
 | Dtex | Enterprise Software Cybersecurity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $266.83MM | Series E | 3/5/2024 | $50MM | $435.13MM | $2.06 | CapitalG | ||||
 | Dolls Kill | Consumer & Lifestyle Clothing, Fashion, Beauty & Apparel | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $61.53MM | Series B | 12/3/2019 | $40MM | $434.66MM | $11.37 | Sequoia Capital | ||||
 | DeepMap | Transportation Autonomous Vehicles | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $100.41MM | Series B | 11/1/2018 | $68MM | $432.95MM | $2.44 | Andreessen Horowitz, GSR Ventures, iSeed Ventures, Accel Partners, Generation Investment Management, Nvidia GPU Ventures | ||||
 | Zeitview | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $289.25MM | Series E-3 | 1/27/2026 | $102.55MM | $432.39MM | $1.00 | Octant Ventures | ||||
 | Read AI | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $81MM | Series B | 10/28/2024 | $50MM | $432.09MM | $22.65 | Smash Capital, Madrona, Goodwater Capital | ||||
 | Supira Medical | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $241.09MM | Series E | 3/26/2025 | $120MM | $431.99MM | $1.35 | Novo Holdings, Qatar Investment Authority, Cormorant Asset Management, TCP, 415 Capital, AMED Ventures, Picard Angst, Unorthodox Ventures | ||||
 | Atlas Card | Fintech Lending | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $101.62MM | Series C | 3/27/2026 | $42MM | $431.43MM | $7.05 | Undisclosed Investors | ||||
 | MagicSchool AI | Education Education Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $62.87MM | Series B | 2/11/2025 | $45MM | $431.07MM | $25.46 | Valor Equity Partners, Bain Capital Ventures, Adobe Ventures, Atreides Management, Smash Capital | ||||
 | AXIOS | Consumer & Lifestyle Entertainment | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $135.81MM | Series D | 11/2/2021 | $84.26MM | $430.63MM | $17.34 | Cox Enterprises | ||||
 | DexCare | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $146MM | Series C | 6/23/2023 | $60MM | $430.46MM | $2.30 | Iconiq Growth, Transformation Capital, Kaiser Permanente Ventures, Define Ventures, Frist Cressey Ventures, SpringRock Ventures | ||||
 | Genesis Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $308.66MM | Series B | 8/10/2023 | $200MM | $430.19MM | $5.11 | Andreessen Horowtiz, Fidelity, BlackRock, Nventures, T. Rowe Price Associates, Rock Springs Capital, Radical Ventures, Menlo Ventures | ||||
 | Poynt | Fintech Payments | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $271.22MM | Series A-1 | 11/13/2018 | $100.79MM | $429.83MM | $13.69 | Elavon, National Australia Bank | ||||
 | Scribd | Consumer & Lifestyle Media | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $74.54MM | Series E | 11/25/2019 | $25MM | $429.65MM | $13.80 | Spectrum Equity | ||||
 | Apnimed | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $259.52MM | Series D-1 | 12/8/2025 | $35MM | $429.39MM | $9.66 | Undisclosed Investors | ||||
 | Attralus | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $344MM | Series B | 2/6/2024 | $172.6MM | $428.81MM | $7.76 | Logos Capital, Janus Henderson Investors, Redmile Group, Samsara BioCapital, Sarissa Capital Management, Surveyor Capital, Vivo Capital, venBio Partners, Alpha Wave Ventures, Bristol Myers Squibb | ||||
 | Asher Biotherapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $1.05B | Series C | 4/16/2024 | $55MM | $428.78MM | $1.16 | RA Capital, AstraZeneca, Bristol Myers Squibb, Janus Henderson Investors, Third Rock Ventures, Wellington Management, Boxer Capital | ||||
 | Get Covered | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $39.97MM | Series B | 6/24/2025 | $25MM | $428.37MM | $20.04 | Undisclosed Investors | ||||
 | OpenX | Enterprise Software Sales & Marketing / Adtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $79.22MM | Series E | 2/26/2013 | $25.01MM | $428.1MM | $1.12 | Samsung Venture Investments, Yet2Ventures, Accel Partners, Index Ventures, SAP Ventures, LocalGlobe, Mitsui Global Investment, Presidio Ventures | ||||
 | Happyrobot | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $61.05MM | Series B-1 | 9/3/2025 | $43.01MM | $427.57MM | $17.32 | Base10 Partners, a16z, Array Ventures, Avra, Samsara Ventures, Tokio Marine, WaVe-X, WiL, YC | ||||